Between 2013 and 2023, the Penicillins and Streptomycins dosage market in South Africa experienced a decrease in market value per capita, from $2.95 to $2.34. In the past two years, there has been a steady decline with a year-on-year decrease, reaching -1.26% by 2023. Over the last five years, the compound annual growth rate (CAGR) was -0.82%, indicating a consistent downward trend.
Looking into the future, watch for:
- Potential policy changes affecting pharmaceutical imports and local production.
- Shifts in healthcare funding and initiatives targeting infectious diseases.
- Technological advancements that might influence antibiotic demand and distribution.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 20 | 20 Nicaragua | 2.37 | 2023 | View data | ||
| 21 | 21 Guatemala | 2.36 | 2023 | View data | ||
| 22 | 22 South Africa | 2.34 | 2023 | |||
| 23 | 23 Moldova | 2.19 | 2023 | View data | ||
| 24 | 24 Brazil | 2.01 | 2023 | View data | ||
